Herantis Pharma Oyj historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2022-12-22 | 1.725 | 1.780 | 1.660 | 1.745 | 1.745 | 5,343 |
| 2022-12-21 | 1.795 | 1.805 | 1.700 | 1.705 | 1.705 | 4,153 |
| 2022-12-20 | 1.940 | 2.100 | 1.710 | 1.750 | 1.750 | 22,089 |
| 2022-12-19 | 1.590 | 1.870 | 1.580 | 1.870 | 1.870 | 30,120 |
| 2022-12-16 | 1.690 | 1.690 | 1.610 | 1.640 | 1.640 | 3,901 |
| 2022-12-15 | 1.670 | 1.685 | 1.650 | 1.685 | 1.685 | 10,145 |
| 2022-12-14 | 1.720 | 1.720 | 1.660 | 1.705 | 1.705 | 4,804 |
| 2022-12-13 | 1.625 | 1.720 | 1.625 | 1.720 | 1.720 | 5,574 |
| 2022-12-12 | 1.705 | 1.730 | 1.590 | 1.730 | 1.730 | 8,580 |
| 2022-12-09 | 1.720 | 1.720 | 1.690 | 1.720 | 1.720 | 1,775 |
| 2022-12-08 | 1.685 | 1.720 | 1.685 | 1.720 | 1.720 | 875 |
| 2022-12-07 | 1.720 | 1.760 | 1.680 | 1.725 | 1.725 | 5,040 |
| 2022-12-05 | 1.725 | 1.780 | 1.680 | 1.705 | 1.705 | 5,227 |
| 2022-12-02 | 1.800 | 1.820 | 1.780 | 1.780 | 1.780 | 1,157 |
| 2022-12-01 | 1.815 | 1.845 | 1.720 | 1.800 | 1.800 | 38,954 |
| 2022-11-30 | 1.705 | 1.705 | 1.705 | 1.705 | 1.705 | 306 |
| 2022-11-29 | 1.760 | 1.815 | 1.735 | 1.735 | 1.735 | 55,450 |
| 2022-11-28 | 1.710 | 1.710 | 1.700 | 1.700 | 1.700 | 811 |
| 2022-11-25 | 1.685 | 1.750 | 1.685 | 1.710 | 1.710 | 51,900 |
| 2022-11-24 | 1.755 | 1.755 | 1.685 | 1.685 | 1.685 | 791 |
| 2022-11-23 | 1.820 | 1.820 | 1.680 | 1.680 | 1.680 | 47,539 |
| 2022-11-22 | 1.820 | 1.885 | 1.815 | 1.815 | 1.815 | 685 |
| 2022-11-21 | 1.830 | 1.855 | 1.805 | 1.855 | 1.855 | 1,779 |
| 2022-11-18 | 1.740 | 1.890 | 1.735 | 1.855 | 1.855 | 64,284 |
| 2022-11-17 | 1.750 | 1.750 | 1.715 | 1.745 | 1.745 | 53,547 |
| 2022-11-16 | 1.780 | 1.780 | 1.720 | 1.745 | 1.745 | 2,396 |
| 2022-11-15 | 1.745 | 1.790 | 1.720 | 1.775 | 1.775 | 69,881 |
| 2022-11-14 | 1.745 | 1.770 | 1.710 | 1.710 | 1.710 | 76,585 |
| 2022-11-11 | 1.730 | 1.780 | 1.720 | 1.720 | 1.720 | 101,790 |
| 2022-11-10 | 1.675 | 1.760 | 1.675 | 1.750 | 1.750 | 103,487 |
| 2022-11-09 | 1.730 | 1.730 | 1.645 | 1.710 | 1.710 | 3,798 |
| 2022-11-08 | 1.630 | 1.700 | 1.630 | 1.695 | 1.695 | 5,925 |
| 2022-11-07 | 1.710 | 1.750 | 1.610 | 1.700 | 1.700 | 4,893 |
| 2022-11-04 | 1.540 | 1.710 | 1.520 | 1.710 | 1.710 | 14,127 |
| 2022-11-03 | 1.630 | 1.630 | 1.590 | 1.590 | 1.590 | 1,343 |
| 2022-11-02 | 1.555 | 1.605 | 1.555 | 1.605 | 1.605 | 441 |
| 2022-11-01 | 1.520 | 1.555 | 1.515 | 1.555 | 1.555 | 1,600 |
| 2022-10-31 | 1.505 | 1.610 | 1.505 | 1.525 | 1.525 | 1,264 |
| 2022-10-28 | 1.630 | 1.645 | 1.500 | 1.540 | 1.540 | 11,920 |
| 2022-10-27 | 1.775 | 1.780 | 1.550 | 1.720 | 1.720 | 11,746 |
| 2022-10-26 | 1.645 | 1.800 | 1.645 | 1.775 | 1.775 | 4,441 |
| 2022-10-25 | 1.685 | 1.785 | 1.525 | 1.645 | 1.645 | 11,333 |
| 2022-10-24 | 1.800 | 1.800 | 1.690 | 1.800 | 1.800 | 2,148 |
| 2022-10-21 | 1.800 | 1.805 | 1.800 | 1.800 | 1.800 | 689 |
| 2022-10-20 | 1.860 | 1.960 | 1.800 | 1.800 | 1.800 | 7,436 |
| 2022-10-19 | 1.840 | 1.850 | 1.840 | 1.850 | 1.850 | 100 |
| 2022-10-18 | 1.870 | 1.870 | 1.870 | 1.870 | 1.870 | 0 |
| 2022-10-17 | 1.770 | 1.870 | 1.770 | 1.870 | 1.870 | 153 |
| 2022-10-14 | 1.780 | 1.940 | 1.780 | 1.940 | 1.940 | 3,320 |
| 2022-10-13 | 1.815 | 1.890 | 1.785 | 1.890 | 1.890 | 50 |
| 2022-10-12 | 1.895 | 1.895 | 1.895 | 1.895 | 1.895 | 100 |
| 2022-10-11 | 1.815 | 1.900 | 1.815 | 1.900 | 1.900 | 1,505 |
| 2022-10-10 | 1.850 | 1.850 | 1.795 | 1.815 | 1.815 | 1,099 |
| 2022-10-07 | 1.895 | 1.900 | 1.795 | 1.795 | 1.795 | 5,229 |
| 2022-10-06 | 1.810 | 1.900 | 1.790 | 1.900 | 1.900 | 5,065 |
| 2022-10-05 | 1.790 | 1.790 | 1.790 | 1.790 | 1.790 | 0 |
| 2022-10-04 | 1.775 | 1.895 | 1.775 | 1.790 | 1.790 | 7,249 |
| 2022-10-03 | 1.770 | 1.860 | 1.770 | 1.800 | 1.800 | 1,462 |
| 2022-09-30 | 1.770 | 1.780 | 1.770 | 1.780 | 1.780 | 825 |
| 2022-09-29 | 1.785 | 1.845 | 1.770 | 1.780 | 1.780 | 4,137 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (EUR). Adjusted close accounts for splits and dividends. Educational only, not financial advice.